Status:
COMPLETED
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone
Lead Sponsor:
BeerYaakov Mental Health Center
Conditions:
Schizophrenia
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.
Eligibility Criteria
Inclusion
- Patients with akathisia according to DSM-IV criteria at least mild akathisia.
Exclusion
- Change of pharmacologic regimen 7 days prior to study entry
- Significant systemic disease
- The presence of chronic akathisia
- Patients unable to cooperate
Key Trial Info
Start Date :
November 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00659919
Start Date
November 1 2000
End Date
December 1 2003
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beer Yaakov MHC
Beer Yaacov, Israel, 70350